Citation 87546

SU,BN: MISICO,R: PARK,EJ: SANTARSIERO,BD: MESECAR,AD: FONG,HHS: PEZZUTO,JM: KINGHORN,AD:. (2002). ISOLATION AND CHARACTERIZATION OF BIOACTIVE PRINCIPLES OF THE LEAVES AND STEMS OF PHYSALIS PHILADELPHICA.. 58(17)

Citation Details

Title	ISOLATION AND CHARACTERIZATION OF BIOACTIVE PRINCIPLES OF THE LEAVES AND STEMS OF PHYSALIS PHILADELPHICA.
Authors	SU,BN: MISICO,R: PARK,EJ: SANTARSIERO,BD: MESECAR,AD: FONG,HHS: PEZZUTO,JM: KINGHORN,AD:
Year	2002
Volume	58
Issue	17

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Physalis philadelphica (SOLANACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHILADELPHICALACTONE A	None
3	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHILADELPHICALACTONE A	ACTIVE
4	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHILADELPHICALACTONE A	ACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHILADELPHICALACTONE B	None
6	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHILADELPHICALACTONE B	ACTIVE
7	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHILADELPHICALACTONE B	ACTIVE
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	IXOCARPALACTONE B	None
9	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	IXOCARPALACTONE B	ACTIVE
10	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IXOCARPALACTONE B	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESQUANTITATIVE DATA	IXOCARPALACTONE A	None
12	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	IXOCARPALACTONE A	ACTIVE
13	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IXOCARPALACTONE A	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	WITHAPHYSACARPIN	None
15	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WITHAPHYSACARPIN	ACTIVE
16	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WITHAPHYSACARPIN	ACTIVE
17	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	WITHANOLIDE D,18-HYDROXY:	None
18	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WITHANOLIDE D,18-HYDROXY:	ACTIVE
19	FUNGAL STIMULANT	PHARMACOLOGY OF COMPOUND - IN VITRO	WITHANOLIDE D,18-HYDROXY:	ACTIVE
20	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	WITHANONE	None
21	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WITHANONE	INACTIVE
22	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	None
23	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	ACTIVE
24	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	ACTIVE
25	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	None
26	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	INACTIVE
27	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:	INACTIVE
28	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OCTADECANE-1-3(S)-4(R)-TRIOL,2(S)-TETRACOSANOYL-AMINO:	None
29	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CHLOROPHYLLIDE ALPHA	None
30	QUINONE REDUCTASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLLIDE ALPHA	INACTIVE
31	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLLIDE ALPHA	ACTIVE

Citation 87546

Citation Details

Summary

Organisms and Their Experiments (1)

Physalis philadelphica (SOLANACEAE)

Show SPARQL Queries (1)

Query 1